CI
GILD icon

Cordant Inc’s Gilead Sciences GILD Stock Holding History

Cordant Inc’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$499 Buy
+4
New +$527 ﹤0.01% 192
2022
Q2 		– Sell
-84
Closed -$5K – 530
2022
Q1 		$5K Buy
+84
New +$5.37K ﹤0.01% 273

Other funds holding GILD

LMFP
Larry Mathis Financial Planning Phoenix, Arizona $124B AUM
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
CIM
Confluence Investment Management St. Louis, Missouri $6.4B AUM 9.79% 1-Year Est. Return
CGH
Crossmark Global Holdings Houston, Texas $7.71B AUM 37.66% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
CNB
Czech National Bank Prague, Czech Republic $18.3B AUM 43.04% 1-Year Est. Return
AP
Atwood & Palmer Kansas City, Missouri $1.87B AUM 24.22% 1-Year Est. Return
COPPSERS
Commonwealth of Pennsylvania Public School Employees Retirement System Harrisburg, Pennsylvania $20.6B AUM 37.37% 1-Year Est. Return

Cordant Inc's GILD Position: Q2 2026 in Review

Cordant Inc opened a new position in Gilead Sciences (GILD) in Q2 2026: 4 shares worth $499. The stake represents ﹤0.01% of the portfolio and ranks #192 among its holdings. This is a return to the name: Cordant Inc previously reported a position in GILD as recently as Q1 2022.

Cordant Inc first reported a position in GILD in Q1 2022 and has held it in 2 quarters since. The position peaked at $5K in Q1 2022. 361 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Cordant Inc held 4 shares of Gilead Sciences worth $499 as of Q2 2026.
  • Gilead Sciences was a new Cordant Inc position in Q2 2026.
  • Gilead Sciences made up ﹤0.01% of Cordant Inc's portfolio in Q2 2026, its #192 holding.
  • Cordant Inc first reported a position in Gilead Sciences in Q1 2022 and has held it in 2 quarters since.
  • Cordant Inc's Gilead Sciences position peaked at $5K in Q1 2022.
  • 361 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Cordant Inc's 13F filing for Q2 2026, filed 15 Jul 2026.